Researchers set out to examine the effects of sodium nitroprusside on the thromboxane-mediated contraction and nitric oxide (NO)-independent relaxation pathways and on reactive oxygen species ...
This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello, and welcome to this podcast series. I'm Dr Vallerie McLaughlin, the Kim A. Eagle Endowed Professor of Cardiovascular ...
BMPER attenuated PI3K/AKT signaling and suppressed BMP4-driven smooth muscle activation in models of PAH. BMPER overexpression mitigated the vascular remodeling that characterizes pulmonary arterial ...
Nitric oxide therapy is an effective, FDA-approved method to treat conditions like hypoxic respiratory failure with pulmonary hypertension in newborns ages 34 weeks and older. Share on Pinterest Jill ...
Please provide your email address to receive an email when new articles are posted on . Among pediatric patients in the Pediatric Pulmonary Hypertension Network, nearly half had group 3 disease, ...
Indication covers newborn infants with hypoxic respiratory failure and peri- and post-operative pulmonary hypertension to improve right ventricular function in conjunction with heart surgery 1) the ...
McLaughlin: Thanks, Ray. That's what we're talking about: PH classification, and what are the causes? There's so many things that can cause PH. And of course, pulmonary arterial hypertension (PAH) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results